NSAIDs API Market: By Molecule Type (Ibuprofen, Aspirin, Paracetmol, Diclofenac, and Others), By Formulation (Tablets, Capsules. Suspension, Topical Presentations, and Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

NSAIDs API Market size was valued at USD x million in 2022 and is poised to grow at a CAGR of x% from 2023-2029. owing to increase in prevalence of arthritis, which is the major cause for the disability and growing number of geriatric population across the globe drives the growth of the market. For instance, According to Center for Disease Control and Prevention (CDC), from 2013-2015, approximately 54.4 Mn US adults had some form of arthritis such as gout, rheumatoid arthritis treatment, fibromyalgia, and lupus and estimated to reach 78 Mn adults aged 18 years older are projected to have arthritis by 2040.  NSAIDs are drug class that groups together drugs that provide analgesic and anti-pyretic effects. Moreover, increasing access to healthcare with the rapid penetration of technology and other developments in the healthcare sector has increased the consumption of drugs, thereby directly creating positive impact on NSAID market.  However, availability of alternative products in the market for NSAIDs and development of advanced medications are expected to hamper the growth of the market. This report studies Global NSAIDs API market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Global NSAIDs API market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the Global NSAIDs API market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in Global NSAIDs API.

Global Nsaids Api Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

x%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Nsaids Api Market Dynamics

Low cost of the non-steroidal anti-inflammatory drugs such as ibuprofen, diclofenac, piroxicam, aspirin, and other drugs coupled with the better availability of the products boost the revenue growth of global NSAIDs market over the forecast years. Formulation of NSAIDs for the patient convenience also enhance the market revenue in the forthcoming years. For instance, Pfizer, Inc. marketing the Flector (Diclofenac Epolamine Topical Patch) to treat acute pain due to minor strains, sprains, and bruises. In addition, NSAIDs also available in the injectable forms which are easy to administer the patients unable to swallow the tablets. Moreover, Mylan laboratories manufacturing Brufen effervescent granules that can be easily administered for the geriatric and paediatric patients

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Nsaids Api Market Segmentation

By Molecule Type
  • Ibuprofen
  • Aspirin
  • Paracetmol
  • Diclofenac
  • Others
By Formulation
  • Tablets
  • Capsules
  • Suspension
  • Topical Presentations
  • Others
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The nsaids api market size was valued at USD x million in 2022

Increased the consumption of drugs

Asia Pacific is the fastest-growing for nsaids api market

1. Executive Summary
2. Global Nsaids Api Market Introduction 
2.1.Global Nsaids Api Market  - Taxonomy
2.2.Global Nsaids Api Market  - Definitions
2.2.1.Molecule Type
2.2.2.Formulation
2.2.3.Region
3. Global Nsaids Api Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Nsaids Api Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Nsaids Api Market  By Molecule Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Ibuprofen
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Aspirin
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Paracetmol
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Diclofenac
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. Global Nsaids Api Market  By Formulation, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Tablets
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Capsules
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Suspension
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Topical Presentations
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Nsaids Api Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Nsaids Api Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Molecule Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Ibuprofen
8.1.2.Aspirin
8.1.3.Paracetmol
8.1.4.Diclofenac
8.1.5.Others
8.2.  Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Tablets
8.2.2.Capsules
8.2.3.Suspension
8.2.4.Topical Presentations
8.2.5.Others
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9. Europe Nsaids Api Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Molecule Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Ibuprofen
9.1.2.Aspirin
9.1.3.Paracetmol
9.1.4.Diclofenac
9.1.5.Others
9.2.  Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Tablets
9.2.2.Capsules
9.2.3.Suspension
9.2.4.Topical Presentations
9.2.5.Others
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
9.3.7.
10. Asia Pacific (APAC) Nsaids Api Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Molecule Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Ibuprofen
10.1.2.Aspirin
10.1.3.Paracetmol
10.1.4.Diclofenac
10.1.5.Others
10.2.  Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Tablets
10.2.2.Capsules
10.2.3.Suspension
10.2.4.Topical Presentations
10.2.5.Others
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11. Middle East and Africa (MEA) Nsaids Api Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Molecule Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Ibuprofen
11.1.2.Aspirin
11.1.3.Paracetmol
11.1.4.Diclofenac
11.1.5.Others
11.2.  Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Tablets
11.2.2.Capsules
11.2.3.Suspension
11.2.4.Topical Presentations
11.2.5.Others
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12. Latin America Nsaids Api Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Molecule Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Ibuprofen
12.1.2.Aspirin
12.1.3.Paracetmol
12.1.4.Diclofenac
12.1.5.Others
12.2.  Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Tablets
12.2.2.Capsules
12.2.3.Suspension
12.2.4.Topical Presentations
12.2.5.Others
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Granules India Ltd. (India)
13.2.2.Xinuha Pharm (China)
13.2.3.IOL Chemicals and Pharmaceuticals Ld. (India)
13.2.4.Strides Pharma Science Limited (India)
13.2.5.SI Group (U.S.)
13.2.6.BASF SE (Germany)
13.2.7.Bayer AG (Germany)
13.2.8.Pfizer, Inc. (U.S.)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Granules India Ltd. (India)
  • Xinuha Pharm (China)
  • IOL Chemicals and Pharmaceuticals Ld. (India)
  • Strides Pharma Science Limited (India)
  • SI Group (U.S.)
  • BASF SE (Germany)
  • Bayer AG (Germany)
  • Pfizer, Inc. (U.S.)

Adjacent Markets